One pill to cure sleeping sickness? new trial raises hopes
NCT ID NCT03087955
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a single oral dose of acoziborole in 208 adults with sleeping sickness, a deadly parasitic disease. Participants took three tablets once and were monitored for 18 months. The goal was to see if this simple treatment could cure both early and late stages of the disease, potentially replacing difficult injections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acoziborole (a single-dose oral pill)
- What this could lead to
- If successful, this could provide a simple, one-time oral cure for sleeping sickness, replacing current complex treatments.
- What could go wrong
- This is a combined Phase 2/3 trial, so results are promising but not yet confirmed in larger populations. Relapse or side effects remain possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GAMBIENSE TRYPANOSOMIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre de Traitement de Kimpese
Kimpese, Bas-Congo Province, Democratic Republic of the Congo
-
Centre de Traitement de Nkara
Nkara, Bandundu, Democratic Republic of the Congo
-
Centre de Traitement de la THA de Dubreka
Dubréka, Dubreka, Guinea
-
Hopital Général de Réference de Bandundu
Bandundu Province, Democratic Republic of the Congo
-
Hôpital Général de Référence Roi Baudouin
Kinshasa, Democratic Republic of the Congo
-
Hôpital Général de Référence de Bagata
Bagata, Kwilu, Democratic Republic of the Congo
-
Hôpital Général de Référence de Kwamouth
Kwamouth, Mai Ndombe, Democratic Republic of the Congo
-
Hôpital Général de Référence de Masi-Manimba
Masi-Manimba, Kwilu, Democratic Republic of the Congo
-
Hôpital Général de Référence de Ngandajika
Gandajika, East Kasai, Democratic Republic of the Congo
-
Hôpital Secondaire de Katanda
Katanda, East Kasai, Democratic Republic of the Congo
-
Hôpital de Dipumba
Mbuji-Mayi, East Kasai, Democratic Republic of the Congo
-
Hôpital de Référence d'Isangi
Isangi, Democratic Republic of the Congo
More trials for these conditions
Other studies related to the condition(s) this trial covers.